AVOCA INNOVATION ALLIANCE Trademark

Trademark Overview

On Friday, June 12, 2020, a trademark application was filed for AVOCA INNOVATION ALLIANCE with the United States Patent and Trademark Office. The USPTO has given the AVOCA INNOVATION ALLIANCE trademark a serial number of 88962186. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Wednesday, February 15, 2023. This trademark is owned by The Avoca Group, Inc.. The AVOCA INNOVATION ALLIANCE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business consulting and management in the field of clinical trials, namely, providing information management services; formulation of best practices for clinical trial execution and management for the testing of drugs, biologics, and medical devices; preparation of business reports related to key trends and innovations in clinical trial execution and management for the testing of drugs, biologics, and medical devices; conducting conferences in the fields of clinical trials for the testing of drugs, biologics, and medical devices for business purposes; association services, namely, promoting the interests of the clinical trial field
avoca innovation alliance

General Information

Serial Number88962186
Word MarkAVOCA INNOVATION ALLIANCE
Filing DateFriday, June 12, 2020
Status711 - CANCELLED - SECTION 7
Status DateWednesday, February 15, 2023
Registration Number6435639
Registration DateTuesday, July 27, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2020

Trademark Statements

Goods and ServicesBusiness consulting and management in the field of clinical trials, namely, providing information management services; formulation of best practices for clinical trial execution and management for the testing of drugs, biologics, and medical devices; preparation of business reports related to key trends and innovations in clinical trial execution and management for the testing of drugs, biologics, and medical devices; conducting conferences in the fields of clinical trials for the testing of drugs, biologics, and medical devices for business purposes; association services, namely, promoting the interests of the clinical trial field
Disclaimer with Predetermined Text"ALLIANCE"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateWednesday, February 15, 2023
Primary Code035
First Use Anywhere DateWednesday, May 12, 2021
First Use In Commerce DateWednesday, May 12, 2021

Trademark Owner History

Party NameThe Avoca Group, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08542
Party NameThe Avoca Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08542
Party NameThe Avoca Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08542

Trademark Events

Event DateEvent Description
Wednesday, February 15, 2023CANCELLED SECTION 7-TOTAL
Wednesday, February 15, 2023NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Friday, September 9, 2022REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Monday, February 13, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 9, 2022TEAS SECTION 7 SURRENDER RECEIVED
Tuesday, July 27, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 22, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 21, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 25, 2021STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 13, 2021USE AMENDMENT FILED
Tuesday, May 25, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 13, 2021TEAS STATEMENT OF USE RECEIVED
Friday, February 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 22, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 27, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 7, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, September 20, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 17, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, September 17, 2020ASSIGNED TO LIE
Thursday, September 17, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 17, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, September 17, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, September 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 17, 2020NON-FINAL ACTION E-MAILED
Thursday, September 17, 2020NON-FINAL ACTION WRITTEN
Thursday, September 17, 2020NON-FINAL ACTION WRITTEN
Tuesday, September 15, 2020ASSIGNED TO EXAMINER
Friday, July 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 16, 2020NEW APPLICATION ENTERED

Related Keywords

alliance innovation avoca clinical management business drugs biologics medical devices trial testing field